The risk or severity of adverse effects can be increased when Ambroxol is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cilastatin. The risk or severity of adverse effects can be increased when Simvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tetrahydropalmatine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ethanol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluoxetine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Spirapril. The risk or severity of adverse effects can be increased when Lomitapide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ketazolam is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Primidone. The metabolism of Atorvastatin can be increased when combined with Rifabutin. The risk or severity of adverse effects can be increased when Testosterone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ivacaftor is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bortezomib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clindamycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Enasidenib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Teriflunomide. The risk or severity of adverse effects can be increased when Aprepitant is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin. The risk or severity of adverse effects can be increased when Darodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Zucapsaicin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Nafamostat. The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with St. John's Wort. The serum concentration of Atorvastatin can be decreased when it is combined with Enzalutamide. The risk or severity of adverse effects can be increased when Tadalafil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Topotecan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nicardipine is combined with Atorvastatin. The serum concentration of Tolvaptan can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Cimetidine. The risk or severity of adverse effects can be increased when Pimozide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cisapride is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Atorvastatin. Gemfibrozil may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Roxithromycin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Delanzomib. The risk or severity of adverse effects can be increased when Raloxifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Quinidine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Capsaicin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Enalapril. The serum concentration of Atorvastatin can be increased when it is combined with Simeprevir. The metabolism of Atorvastatin can be increased when combined with Rifapentine. The risk or severity of adverse effects can be increased when Nifedipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Regorafenib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clotiazepam is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Gliclazide. The serum concentration of Atorvastatin can be increased when it is combined with Benzamidine. The serum concentration of Atorvastatin can be increased when it is combined with Epigallocatechin Gallate. The risk or severity of adverse effects can be increased when Vincristine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Repaglinide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Doxycycline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxybutynin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Moexipril. The risk or severity of adverse effects can be increased when Omeprazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clemastine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Lumacaftor. The serum concentration of Atorvastatin can be increased when it is combined with Isoflurophate. The risk or severity of adverse effects can be increased when Idelalisib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Z-Val-Ala-Asp fluoromethyl ketone. The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with 4-(2-Aminoethyl)Benzenesulfonyl Fluoride. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Daptomycin. The serum concentration of Atorvastatin can be increased when it is combined with Linagliptin. The serum concentration of Atorvastatin can be increased when it is combined with Chymostatin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with 3,4-Dichloroisocoumarin. The risk or severity of adverse effects can be increased when Paramethasone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Dasatinib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Lisinopril. The risk or severity of adverse effects can be increased when Antipyrine is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Ethyl biscoumacetate. The serum concentration of Atorvastatin can be increased when it is combined with Indinavir. The risk or severity of adverse effects can be increased when Mefloquine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Metyrapone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nevirapine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Colesevelam. Atorvastatin may increase the hypoglycemic activities of Insulin Pork. The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine. The serum concentration of Atorvastatin can be increased when it is combined with Sivelestat. The risk or severity of adverse effects can be increased when Crizotinib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Zofenopril. The risk or severity of adverse effects can be increased when Quinupristin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Dexamethasone is combined with Atorvastatin. The serum concentration of Naloxegol can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rucaparib is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Tromethamine. The serum concentration of Atorvastatin can be increased when it is combined with Ubenimex. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prenylamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Spironolactone. The risk or severity of adverse effects can be increased when Miconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Diethylstilbestrol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Troglitazone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sitaxentan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Albaconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Modafinil is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Sodium bicarbonate. The serum concentration of Atorvastatin can be increased when it is combined with Eltrombopag. The risk or severity of adverse effects can be increased when Tioconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Acetazolamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tramadol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Carboxyamidotriazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prednisone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Temsirolimus is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cobicistat. The risk or severity of adverse effects can be increased when Elbasvir is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ixazomib. Acipimox may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Caspofungin is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glibornuride. The risk or severity of adverse effects can be increased when Histamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Barnidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Risedronate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Astemizole is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Magnesium oxide. The serum concentration of Dabigatran etexilate can be decreased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Bismuth Subcitrate. The risk or severity of adverse effects can be increased when Tamoxifen is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Spiramycin is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Phenobarbital. The serum concentration of Atorvastatin can be increased when it is combined with Captopril. The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Atorvastatin. The serum concentration of Cilostazol can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Prinomastat. The risk or severity of adverse effects can be increased when Metronidazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Elafin. The serum concentration of Atorvastatin can be increased when it is combined with Danazol.